Donna Mabry Hrones

Statistics

Publications

Citations

190

H-Index

Active since

2021

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Mater Misericordiae University Hospital

National Institutes of Health Clinical Center

Donna Mabry Hrones is an author at National Cancer Institute specializing in oncology, resistance to immune checkpoint inhibition, and immune checkpoint blockade combinations.

Publications per year

2021–2025

Publications

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma

Tim F. Greten, Ghassan K. Abou‐Alfa, Ann‐Lii Cheng et al. · Journal for ImmunoTherapy of Cancer · 2021 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Cecilia Monge, Changqing Xie, Yuta Myojin et al. · Journal for ImmunoTherapy of Cancer · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

Yuta Myojin, Sepideh Babaei, Rajiv Trehan et al. · Gut · 2025 · 18 citations · Full text

Medicine, Immunology, Oncology +17

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Kelley Coffman, Yuta Myojin, Cecilia Monge et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

Medicine, Immunology, Oncology +17

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cecilia Monge, Changqing Xie, Yuta Myojin et al. · Cancer Medicine · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5